Genetic variation in selenoprotein genes, lifestyle, and risk of colon and rectal cancer

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Slattery, Martha L ^a   Lundgreen, Abbie ^a   Welbourn, Bill ^b   Corcoran, Christopher ^b   Wolff, Roger K ^a  

^a UNIVERSITY OF UTAH HEALTH SCIENCES CENTER   (United States)

^b UTAH STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ESTROGEN; NONSTEROID ANTIINFLAMMATORY AGENT; SELENOPROTEIN; MUSCLE PROTEIN; SEPN1 PROTEIN, HUMAN; THIOREDOXIN REDUCTASE; THIOREDOXIN REDUCTASE 2; TXNRD2 PROTEIN, HUMAN; TXNRD3 PROTEIN, HUMAN;

ARTICLE; CANCER RISK; CANCER SURVIVAL; CARCINOGENESIS; COLON CANCER; CONTROLLED STUDY; DATA ANALYSIS; DRUG EXPOSURE; GENE FREQUENCY; GENE FUNCTION; GENE IDENTIFICATION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; HUMAN; LIFESTYLE; MAJOR CLINICAL STUDY; ONCOGENE; POPULATION BASED CASE CONTROL STUDY; RECTUM CANCER; SELH GENE; SELN1 GENE; SELS GENE; SELW GENE; SEP15 GENE; SEPX GENE; SINGLE NUCLEOTIDE POLYMORPHISM; TXNRD1 GENE; TXNRD2 GENE; TXNRD3 GENE; ADULT; AGED; CASE CONTROL STUDY; COLON TUMOR; COLORECTAL TUMOR; FEMALE; GENETIC PREDISPOSITION; GENETICS; MALE; MIDDLE AGED; MORTALITY; OBESITY; RECTUM TUMOR; RISK; SMOKING; SURVIVAL;

ADULT; AGED; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ASPIRIN; CASE-CONTROL STUDIES; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; ESTROGENS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; LIFE STYLE; MALE; MIDDLE AGED; MUSCLE PROTEINS; OBESITY; RECTAL NEOPLASMS; RISK; SELENOPROTEINS; SMOKING; SURVIVAL ANALYSIS; THIOREDOXIN REDUCTASE 2; THIOREDOXIN-DISULFIDE REDUCTASE;

EID: 84861219891     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0037312     Document Type: Article

References (40)

1. Gresner P, Gromadzinska J, Jablonska E, Kaczmarski J, Wasowicz W, (2009) Expression of selenoprotein-coding genes SEPP1, SEP15 and hGPX1 in non-small cell lung cancer. Lung Cancer 65: 34-40.
2. Clark LC, Combs GF, Turnbull BW, Slate EH, Chalker DK, et al. (1996) Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial. Nutritional Prevention of Cancer Study Group. Jama 276: 1957-1963.
3. Peters U, Chatterjee N, Church TR, Mayo C, Sturup S, et al. (2006) High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program. Cancer Epidemiol Biomarkers Prev 15: 315-320.
4. Shchedrina VA, Zhang Y, Labunskyy VM, Hatfield DL, Gladyshev VN, (2010) Structure-function relations, physiological roles, and evolution of mammalian ER-resident selenoproteins. Antioxid Redox Signal 12: 839-849.
5. Burk RF, Hill KE, Motley AK, (2003) Selenoprotein metabolism and function: evidence for more than one function for selenoprotein P. J Nutr 133: 1517S-1520S.
6. Behne D, Kyriakopoulos A, (2001) Mammalian selenium-containing proteins. Annu Rev Nutr 21: 453-473.
7. Lothrop AP, Ruggles EL, Hondal RJ, (2009) No selenium required: reactions catalyzed by mammalian thioredoxin reductase that are independent of a selenocysteine residue. Biochemistry 48: 6213-6223.
8. Poerschke RL, Moos PJ, (2011) Thioredoxin reductase 1 knockdown enhances selenazolidine cytotoxicity in human lung cancer cells via mitochondrial dysfunction. Biochemical pharmacology 81: 211-221.
9. Sibbing D, Pfeufer A, Perisic T, Mannes AM, Fritz-Wolf K, et al. (2011) Mutations in the mitochondrial thioredoxin reductase gene TXNRD2 cause dilated cardiomyopathy. European heart journal 32: 1121-1133.
10. Arner ES, (2009) Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochimica et biophysica acta 1790: 495-526.
11. Arner ES, (2009) Focus on mammalian thioredoxin reductases-important selenoproteins with versatile functions. Biochim Biophys Acta 1790: 495-526.
12. Kumaraswamy E, Malykh A, Korotkov KV, Kozyavkin S, Hu Y, et al. (2000) Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology. J Biol Chem 275: 35540-35547.
13. Kim YJ, Chai YG, Ryu JC, (2005) Selenoprotein W as molecular target of methylmercury in human neuronal cells is down-regulated by GSH depletion. Biochem Biophys Res Commun 330: 1095-1102.
14. Meplan C, Hesketh J, (2012) The influence of selenium and selenoprotein gene variants on colorectal cancer risk. Mutagenesis 27: 177-186.
15. Fradejas N, Serrano-Perez Mdel C, Tranque P, Calvo S, (2011) Selenoprotein S expression in reactive astrocytes following brain injury. Glia 59: 959-972.
16. Haug U, Poole EM, Xiao L, Curtin K, Duggan D, et al. (2012) Glutathione peroxidase tagSNPs: Associations with rectal cancer but not with colon cancer. Genes, chromosomes & cancer.
17. Slattery MLLA, Welbourn B, Wolff RK, Corcoran C, (2012) Oxidative Balance and Colon and Rectal Cancer: Interaction of lifestyle factors and genes. Mutation Research.
18. Damdimopoulos AE, Miranda-Vizuete A, Treuter E, Gustafsson JA, Spyrou G, (2004) An alternative splicing variant of the selenoprotein thioredoxin reductase is a modulator of estrogen signaling. J Biol Chem 279: 38721-38729.
19. Zhou X, Smith AM, Failla ML, Hill KE, Yu Z, (2011) Estrogen status alters tissue distribution and metabolism of selenium in female rats. J Nutr Biochem.
20. Irons R, Tsuji PA, Carlson BA, Ouyang P, Yoo MH, et al. (2010) Deficiency in the 15-kDa selenoprotein inhibits tumorigenicity and metastasis of colon cancer cells. Cancer Prev Res (Phila) 3: 630-639.
21. Slattery ML, Potter J, Caan B, Edwards S, Coates A, et al. (1997) Energy balance and colon cancer-beyond physical activity. Cancer Res 57: 75-80.
22. Slattery ML, Edwards S, Curtin K, Ma K, Edwards R, et al. (2003) Physical activity and colorectal cancer. Am J Epidemiol 158: 214-224.
23. Edwards S, Slattery ML, Mori M, Berry TD, Caan BJ, et al. (1994) Objective system for interviewer performance evaluation for use in epidemiologic studies. Am J Epidemiol 140: 1020-1028.
24. Slattery ML, Caan BJ, Duncan D, Berry TD, Coates A, et al. (1994) A computerized diet history questionnaire for epidemiologic studies. J Am Diet Assoc 94: 761-766.
25. Liu K, Slattery M, Jacobs D, Cutter G, McDonald A, et al. (1994) A study of the reliability and comparative validity of the cardia dietary history. Ethn Dis 4: 15-27.
26. Conneely KN, Boehnke M, (2007) So Many Correlated Tests, So Little Time! Rapid Adjustment of P Values for Multiple Correlated Tests. Am J Hum Genet 81: 1158-1168.
27. Holm S, (1979) A simple sequentially rejective multiple test procedure. Scand J Stat 6: 65-70.
28. Westfall PH, Zaykin DV, Young SS, (2002) Multiple tests for genetic effects in association studies. Methods Mol Biol 184: 143-168.
29. Welbourn B, (2012) An exact approach to testing for gene-environment interactions Logan Utah State University.
30. Samowitz WS, Albertsen H, Herrick J, Levin TR, Sweeney C, et al. (2005) Evaluation of a large, population-based sample supports a CpG island methylator phenotype in colon cancer. Gastroenterology 129: 837-845.
31. Samowitz WS, Curtin K, Ma KN, Schaffer D, Coleman LW, et al. (2001) Microsatellite instability in sporadic colon cancer is associated with an improved prognosis at the population level. Cancer Epidemiol Biomarkers Prev 10: 917-923.
32. Slattery ML, Anderson K, Curtin K, Ma K, Schaffer D, et al. (2001) Lifestyle factors and Ki-ras mutations in colon cancer tumors. Mutat Res 483: 73-81.
33. Slattery ML, Curtin K, Ma K, Edwards S, Schaffer D, et al. (2002) Diet activity, and lifestyle associations with p53 mutations in colon tumors. Cancer Epidemiol Biomarkers Prev pp. 541-548.
34. Zhu X, Huang C, Peng B, (2011) Overexpression of thioredoxin system proteins predicts poor prognosis in patients with squamous cell carcinoma of the tongue. Oral Oncol 47: 609-614.
35. Sun QA, Wu Y, Zappacosta F, Jeang KT, Lee BJ, et al. (1999) Redox regulation of cell signaling by selenocysteine in mammalian thioredoxin reductases. J Biol Chem 274: 24522-24530.
36. Schenk H, Klein M, Erdbrugger W, Droge W, Schulze-Osthoff K, (1994) Distinct effects of thioredoxin and antioxidants on the activation of transcription factors NF-kappa B and AP-1. Proc Natl Acad Sci U S A 91: 1672-1676.
37. Peters U, Chatterjee N, Hayes RB, Schoen RE, Wang Y, et al. (2008) Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma. Cancer Epidemiol Biomarkers Prev 17: 1144-1154.
38. Meplan C, Hughes DJ, Pardini B, Naccarati A, Soucek P, et al. (2010) Genetic variants in selenoprotein genes increase risk of colorectal cancer. Carcinogenesis 31: 1074-1079.
39. Hesketh J, Meplan C, (2011) Transcriptomics and functional genetic polymorphisms as biomarkers of micronutrient function: focus on selenium as an exemplar. Proc Nutr Soc pp. 1-9.
40. Slattery ML, Caan BJ, Benson J, Murtaugh M, (2003) Energy balance and rectal cancer: an evaluation of energy intake, energy expenditure, and body mass index. Nutr Cancer 46: 166-171.